Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Non-Current Assets (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Other Non-Current Assets for 6 consecutive years, with $15.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Assets rose 150.67% year-over-year to $15.0 million, compared with a TTM value of $15.0 million through Dec 2024, up 150.67%, and an annual FY2024 reading of $15.0 million, up 150.67% over the prior year.
  • Other Non-Current Assets was $15.0 million for Q4 2024 at Cresco Labs, up from $6.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $15.0 million in Q4 2024 and bottomed at $2.2 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $6.0 million, with a median of $4.4 million recorded in 2020.
  • The sharpest move saw Other Non-Current Assets tumbled 42.3% in 2021, then soared 175.7% in 2023.
  • Year by year, Other Non-Current Assets stood at $4.4 million in 2020, then plummeted by 42.3% to $2.6 million in 2021, then fell by 15.24% to $2.2 million in 2022, then skyrocketed by 175.7% to $6.0 million in 2023, then skyrocketed by 150.67% to $15.0 million in 2024.
  • Business Quant data shows Other Non-Current Assets for CRLBF at $15.0 million in Q4 2024, $6.0 million in Q4 2023, and $2.2 million in Q4 2022.